• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. EARLY ESTIMATES OF SEASONAL INFLUENZA VACCINE EFFECTIVENESS IN EUROPE, 2010/11: I-MOVE, A MULTICENTRE CASE?CONTROL STUDY [Vaccines effe

Giuseppe

Emeritus
EARLY ESTIMATES OF SEASONAL INFLUENZA VACCINE EFFECTIVENESS IN EUROPE, 2010/11: I-MOVE, A MULTICENTRE CASE?CONTROL STUDY (Euro Surveill., abstract, edited)

[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]

Eurosurveillance, Volume 16, Issue 11, 17 March 2011

Rapid communications

EARLY ESTIMATES OF SEASONAL INFLUENZA VACCINE EFFECTIVENESS IN EUROPE, 2010/11: I-MOVE, A MULTICENTRE CASE?CONTROL STUDY

E Kissling 1, M Valenciano 1, I-MOVE case?control studies team 2

1 EpiConcept, Paris, France
2 Members of the team are listed at the end of the article

Citation style for this article: Kissling E, Valenciano M, I-MOVE case?control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case?control study. Euro Surveill. 2011;16(11):pii=19818. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19818

Date of submission: 11 March 2011

We present early estimates (up to week 4 of 2011) of the 2010/11 seasonal influenza vaccine effectiveness in preventing medically attended influenza-like illness (ILI) laboratory confirmed as influenza. Practitioners from seven European sentinel networks systematically swabbed ILI patients. We included patients meeting the European Union ILI case definition and swabbed less than eight days after symptom onset. Laboratory-confirmed influenza cases were compared with negative controls. The adjusted vaccine effectiveness was 42.3% (95% CI: ?7.3 to 69.0%), suggesting moderate protection of the seasonal vaccine.

-
------
 
Back
Top Bottom